SCHEMBL5523012

SCHEMBL5523012

CCCC/C=C\CCCCCCCCOC=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR3 Q9UBY5 4/20 0.55
LPAR2 Q9HBW0 3/20 0.55
LPAR1 Q92633 2/20 0.55
FAAH O00519 3/20 0.54
TRPV1 Q8NER1 2/20 0.54
F7 P08709 1/20 0.47
F3 P13726 1/20 0.47
TSHR P16473 1/20 0.43
GMNN O75496 1/20 0.42
USP2 O75604 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
ALOX15 P16050 1/20 0.42
APEX1 P27695 1/20 0.42
CYP2C19 P33261 1/20 0.42
RECQL P46063 1/20 0.42
BLM P54132 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31508863 1.00 LPAR3 (0.55) LPAR3LPAR2LPAR1FAAHTRPV1
SCHEMBL727768 1.00 LPAR3 (0.55) LPAR3LPAR2LPAR1FAAHTRPV1
SCHEMBL727767 1.00 LPAR3 (0.55) LPAR3LPAR2LPAR1FAAHTRPV1
SCHEMBL10604000 1.00 LPAR3 (0.55) LPAR3LPAR2LPAR1FAAHTRPV1
SCHEMBL11072895 1.00 LPAR3 (0.55) LPAR3LPAR2LPAR1FAAHTRPV1
SCHEMBL10603998 1.00 LPAR3 (0.55) LPAR3LPAR2LPAR1FAAHTRPV1
SCHEMBL11072902 1.00 LPAR3 (0.55) LPAR3LPAR2LPAR1FAAHTRPV1
SCHEMBL13048889 0.96 FAAH (0.59) LPAR3LPAR2LPAR1FAAHTRPV1
SCHEMBL9618002 0.96 FAAH (0.59) LPAR3LPAR2LPAR1FAAHTRPV1
SCHEMBL21642616 0.96 FAAH (0.59) LPAR3LPAR2LPAR1FAAHTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 US claimed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 EP claimed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 WO claimed
EP-4234522-A2 PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS Provivi, Inc. (US) 2023-08-30 EP claimed
EP-3377465-B1 PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS PROVIVI INC (US) 2023-08-02 EP claimed
CN-108473390-B Production of aliphatic olefin derivatives by olefin metathesis 普罗维维公司 2022-08-09 CN claimed
US-11077433-B2 Production of fatty olefin derivatives via olefin metathesis PROVIVI, INC. (US) 2021-08-03 US claimed
US-20200261898-A1 PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS PROVIVI, INC. (US) 2020-08-20 US claimed
EP-1135021-B1 SUSTAINED RELEASE DISPERSIONS OF POLYMER-BASED WATER INSOLUBLE BEADS UNIV BEN GURION (IL) 2004-06-09 EP claimed
EP-1135021-A1 SUSTAINED RELEASE POLYMER-BASED WATER INSOLUBLE BEADS Ben Gurion University Of The Negev Research And Development Authority (IL) 2001-09-26 EP claimed
WO-2000032043-B1 SUSTAINED RELEASE POLYMER-BASED WATER INSOLUBLE BEADS UNIV BEN GURION (IL) 2000-09-08 WO claimed
WO-2000032043-A1 SUSTAINED RELEASE POLYMER-BASED WATER INSOLUBLE BEADS BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) 2000-06-08 WO claimed
US-4487759-A PHEROMONES IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1984-12-11 US claimed
EP-0047261-B1 STABILISED COMPOSITIONS CONTAINING BEHAVIOUR MODIFYING COMPOUNDS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1984-06-20 EP claimed
EP-0047261-A1 STABILISED COMPOSITIONS CONTAINING BEHAVIOUR MODIFYING COMPOUNDS. ICI PLC (GB) 1982-03-17 EP claimed
WO-1981002505-A1 STABILISED COMPOSITIONS CONTAINING BEHAVIOUR MODIFYING COMPOUNDS ICI LTD (GB) 1981-09-17 WO claimed
US-4083995-A INSECT CONTROL THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1978-04-11 US claimed
US-20260091067-A1 METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES MARVELBIOME INC (US) 2026-04-02 US disclosed
US-4083995-A INSECT CONTROL THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1978-04-11 US disclosed
US-4057593-A FROM PHOSPHONIUM SALT AND ALDEHYDE HOECHST AKTIENGESELLSCHAFT (DT) 1977-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200261898-A1 PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS SREBF1, F2, SREBF2 LPAR3 1971/4885LPAR2 2224/4885LPAR1 2254/4885
US-20260091067-A1 METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES IAPP, GPR119, FAHD1 LPAR3 1958/4885LPAR2 824/4885LPAR1 1365/4885
US-11077433-B2 Production of fatty olefin derivatives via olefin metathesis SREBF1, F2, SREBF2 LPAR3 1971/4885LPAR2 2224/4885LPAR1 2254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.